17 Aug Eltroxin New Formulation (25 Mcg, 50 Mcg, 75 Mcg, 100 And 200 Mcg Tablets: Increased Adverse Events Reports And Requirement For Patient Therapeutic Monitoring By Healthcare Professionals.
Posted at 12:31h
in
Pharmacare, in consultation with the South African Health Products Regulatory Authority (SAHPRA) would like to warn healthcare professionals about an increase of adverse events/side effects associated with the introduction of Eltroxin New Formulation® and a call for therapeutic drug monitoring in patients using or switched to the agent.
2020 Dec
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
09/12/2020
File Type:
pdf
Category:
Communication To Health Care Professionals